These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 33863619)

  • 21. Risk factors and oncological outcome for intravesical recurrence in organ-confined upper urinary tract urothelial carcinoma patients after radical nephroureterectomy: A propensity score-matched case control study.
    Jiang Y; Yao Z; Zhu X; Wu B; Bai S
    Int J Surg; 2020 Apr; 76():28-34. PubMed ID: 32081714
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-term endoscopic management of upper tract urothelial carcinoma: 20-year single-centre experience.
    Cutress ML; Stewart GD; Wells-Cole S; Phipps S; Thomas BG; Tolley DA
    BJU Int; 2012 Dec; 110(11):1608-17. PubMed ID: 22564677
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Impact of Preoperative Severe Renal Insufficiency on Poor Postsurgical Oncological Prognosis in Patients with Urothelial Carcinoma.
    Momota M; Hatakeyama S; Tokui N; Sato T; Yamamoto H; Tobisawa Y; Yoneyama T; Yoneyama T; Hashimoto Y; Koie T; Narita S; Kawaguchi T; Ohyama C
    Eur Urol Focus; 2019 Nov; 5(6):1066-1073. PubMed ID: 29548907
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diagnostic Ureterorenoscopy Is Associated with Increased Intravesical Recurrence following Radical Nephroureterectomy in Upper Tract Urothelial Carcinoma.
    Sung HH; Jeon HG; Han DH; Jeong BC; Seo SI; Lee HM; Choi HY; Jeon SS
    PLoS One; 2015; 10(11):e0139976. PubMed ID: 26556239
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diagnostic ureteroscopy prior to nephroureterectomy for urothelial carcinoma is associated with a high risk of bladder recurrence despite technical precautions to avoid tumor spillage.
    Baboudjian M; Al-Balushi K; Michel F; Lannes F; Akiki A; Gaillet S; Delaporte V; Ragni E; Toledano H; Karsenty G; Rossi D; Bastide C; Lechevallier E; Boissier R
    World J Urol; 2020 Jan; 38(1):159-165. PubMed ID: 30993427
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of distal ureter management on oncologic outcomes following radical nephroureterectomy for upper tract urothelial carcinoma.
    Xylinas E; Rink M; Cha EK; Clozel T; Lee RK; Fajkovic H; Comploj E; Novara G; Margulis V; Raman JD; Lotan Y; Kassouf W; Fritsche HM; Weizer A; Martinez-Salamanca JI; Matsumoto K; Zigeuner R; Pycha A; Scherr DS; Seitz C; Walton T; Trinh QD; Karakiewicz PI; Matin S; Montorsi F; Zerbib M; Shariat SF;
    Eur Urol; 2014 Jan; 65(1):210-7. PubMed ID: 22579047
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical implications of intravesical recurrence after radical nephroureterectomy for upper urinary tract urothelial carcinoma.
    Yamashita S; Ito A; Mitsuzuka K; Tochigi T; Namima T; Soma F; Aizawa M; Ioritani N; Kaiho Y; Arai Y
    Int J Urol; 2016 May; 23(5):378-84. PubMed ID: 26780531
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Incidence, characteristics, treatment strategies, and oncologic outcomes of synchronous bilateral upper tract urothelial carcinoma in the Chinese population.
    Fang D; Xiong G; Li X; Kang Y; Zhang L; Zhao G; Chen X; Yao L; Zhang X; Yu W; Gong K; Song Y; He Q; He Z; Zhou L; Guo Y
    Urol Oncol; 2015 Feb; 33(2):66.e1-11. PubMed ID: 25240760
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Impact of Diagnostic Ureteroscopy Prior to Radical Nephroureterectomy on Oncological Outcomes in Patients with Upper Tract Urothelial Carcinoma: A Comprehensive Systematic Review and Meta-Analysis.
    Nowak Ł; Krajewski W; Chorbińska J; Kiełb P; Sut M; Moschini M; Teoh JY; Mori K; Del Giudice F; Laukhtina E; Lonati C; Kaliszewski K; Małkiewicz B; Szydełko T
    J Clin Med; 2021 Sep; 10(18):. PubMed ID: 34575307
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Independent predictors for bladder outcomes after treatment of intravesical recurrence following radical nephroureterectomy in patients with primary upper tract urothelial carcinoma.
    Tanaka N; Kikuchi E; Kanao K; Matsumoto K; Shirotake S; Kobayashi H; Miyazaki Y; Ide H; Obata J; Hoshino K; Hayakawa N; Hagiwara M; Kosaka T; Oyama M; Miyajima A; Momma T; Nakagawa K; Jinzaki M; Hasegawa S; Nakajima Y; Oya M
    Ann Surg Oncol; 2014 Sep; 21(9):3151-8. PubMed ID: 24682698
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The characteristics of recurrent upper tract urothelial carcinoma after radical nephroureterectomy without bladder cuff excision.
    Kang M; Jeong CW; Kwak C; Kim HH; Ku JH
    Yonsei Med J; 2015 Mar; 56(2):375-81. PubMed ID: 25683984
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Upper tract urothelial carcinoma: Paradigm shift towards nephron sparing management.
    Fiuk JV; Schwartz BF
    World J Nephrol; 2016 Mar; 5(2):158-65. PubMed ID: 26981440
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of oncologic and functional outcomes between radical nephroureterectomy and segmental ureterectomy for upper urinary tract urothelial carcinoma.
    Kim TH; Lee CU; Kang M; Jeon HG; Jeong BC; Seo SI; Jeon SS; Lee HM; Sung HH
    Sci Rep; 2021 Apr; 11(1):7828. PubMed ID: 33837237
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Preoperative Monocyte-to-lymphocyte Ratio Predicts for Intravesical Recurrence in Patients With Urothelial Carcinoma of the Upper Urinary Tract After Radical Nephroureterectomy Without a History of Bladder Cancer.
    Liu J; Wu P; Lai S; Song X; Fu C; Wang X; Liu S; Hou H; Liu M; Wang J
    Clin Genitourin Cancer; 2021 Jun; 19(3):e156-e165. PubMed ID: 33121908
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Upper urinary tract recurrence following bladder cancer therapy: a review of surveillance and management.
    Naser-Tavakolian A; Ghodoussipour S; Djaladat H
    Curr Opin Urol; 2019 May; 29(3):189-197. PubMed ID: 30762673
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Concurrent radical cystectomy and nephroureterectomy indications and outcomes: a systematic review and comparative analysis.
    Zein M; Nasrallah AA; Abou Heidar NF; Najdi J; Hneiny L; El Hajj A
    Ther Adv Urol; 2023; 15():17562872231171757. PubMed ID: 37188157
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bladder mapping of tumour recurrence after radical nephroureterectomy for upper tract urothelial carcinoma and its influence on oncological outcomes.
    Belhadj Y; Grande P; Seisen T; Gobert A; Gomez FD; Cussenot O; Roupret M
    BJU Int; 2019 Apr; 123(4):618-623. PubMed ID: 30548115
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic value of plasma fibrinogen levels in patients with localized upper tract urothelial carcinoma.
    Tanaka N; Kikuchi E; Matsumoto K; Hayakawa N; Ide H; Miyajima A; Nakamura S; Oya M
    BJU Int; 2013 May; 111(6):857-64. PubMed ID: 22757942
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Impact of Surgical Waiting Time on Oncological Outcomes in Patients with Upper Tract Urothelial Carcinoma Undergoing Radical Nephroureterectomy: A Systematic Review.
    Nowak Ł; Krajewski W; Łaszkiewicz J; Małkiewicz B; Chorbińska J; Del Giudice F; Mori K; Moschini M; Kaliszewski K; Rajwa P; Laukhtina E; Shariat SF; Szydełko T; On Behalf Of European Association Of Urology Eau-Young Academic Urologists Yau Urothelial Cancer Working Party
    J Clin Med; 2022 Jul; 11(14):. PubMed ID: 35887771
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Systematic Review on the Fate of the Remnant Urothelium after Radical Cystectomy.
    Gakis G; Black PC; Bochner BH; Boorjian SA; Stenzl A; Thalmann GN; Kassouf W
    Eur Urol; 2017 Apr; 71(4):545-557. PubMed ID: 27720534
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.